Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis

Published:2022-05-15 Issue:1 Volume:77 Page:239-255
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Yan Tingting,Luo Yuhong,Yan Nana,Hamada Keisuke,Zhao Nan,Xia Yangliu,Wang Ping,Zhao Changdong,Qi Dan,Yang Shoumei,Sun Lulu,Cai Jie,Wang Qiong,Jiang Changtao,Gavrilova Oksana,Krausz Kristopher W.,Patel Daxesh P.,Yu Xiaoting,Wu Xuan,Hao Haiping,Liu Weiwei,Qu Aijuan,Gonzalez Frank J.

Funder

Data Center of Management Science, National Natural Science Foundation of China - Peking University

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32538

Reference38 articles.

1. Non‐alcoholic fatty liver disease − a global public health perspective;J Hepatol,2019

2. Global epidemiology of NAFLD‐related HCC: trends, predictions, risk factors and prevention;Nat Rev Gastroenterol Hepatol,2021

3. Current and upcoming pharmacotherapy for non‐alcoholic fatty liver disease;Gut,2017